Free Trial

MetLife (MET) Stock Price, News & Analysis

$74.08
-2.50 (-3.26%)
(As of 09/6/2024 ET)
Today's Range
$73.82
$76.95
50-Day Range
$67.96
$77.80
52-Week Range
$57.91
$79.34
Volume
4.99 million shs
Average Volume
3.35 million shs
Market Capitalization
$52.68 billion
P/E Ratio
25.46
Dividend Yield
2.94%
Price Target
$84.54

MetLife MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.92 Rating Score
Upside/​Downside
14.1% Upside
$84.54 Price Target
Short Interest
Healthy
1.19% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.75
Upright™ Environmental Score
News Sentiment
0.59mentions of MetLife in the last 14 days
Based on 18 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.36%
From $8.68 to $9.84 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.99 out of 5 stars

Finance Sector

5th out of 871 stocks

Life Insurance Industry

2nd out of 20 stocks

MET stock logo

About MetLife Stock (NYSE:MET)

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.

MET Stock Price History

MET Stock News Headlines

Giants vs. Vikings: Week 1 staff picks and predictions
What is Nvidia’s New $1 Trillion SuperProject?
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …
MetLife (NYSE:MET) Receives New Coverage from Analysts at Barclays
Giants vs. Vikings: 5 things to know about Week 1
What is Nvidia’s New $1 Trillion SuperProject?
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …
MetLife on Track for Record High Close — Data Talk
Bengals vs. Giants Week 6 Tickets
MetLife Corporate Leadership Awards Digital Showcase
See More Headlines
Receive MET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MetLife and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/11 Dividend
5/06/2024
Dividend Payable
6/11/2024
Last Earnings
7/31/2024
Ex-Dividend for 9/10 Dividend
8/06/2024
Today
9/07/2024
Dividend Payable
9/10/2024
Next Earnings (Estimated)
11/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Life insurance
Sub-Industry
Life & Health Insurance
CUSIP
59156R10
Employees
45,000
Year Founded
1868

Price Target and Rating

Average Stock Price Target
$84.54
High Stock Price Target
$96.00
Low Stock Price Target
$71.00
Potential Upside/Downside
+14.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.92
Research Coverage
13 Analysts

Profitability

Net Income
$1.58 billion
Pretax Margin
5.41%

Debt

Sales & Book Value

Annual Sales
$67.95 billion
Cash Flow
$6.42 per share
Book Value
$39.33 per share

Miscellaneous

Free Float
708,919,000
Market Cap
$52.68 billion
Optionable
Optionable
Beta
1.04

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Should I Buy MetLife Stock? MET Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in MetLife, Inc.:

  • MetLife, Inc. reported earnings per share (EPS) of $2.28 for the quarter, beating analysts' consensus estimates by $0.15. This indicates strong financial performance.
  • The company has a return on equity of 21.41%, showcasing efficient utilization of shareholder equity to generate profits.
  • MetLife's quarterly revenue was up 7.2% year-over-year, demonstrating growth in its core business operations.
  • MetLife initiated a share repurchase plan to buy back $3.00 billion in shares, signaling confidence in the company's value and potential for growth.
  • The company offers a quarterly dividend with a yield of 3.13%, providing investors with a steady income stream.

Cons

Investors should be bearish about investing in MetLife, Inc. for these reasons:

  • MetLife's current ratio and quick ratio are both at 0.16, indicating potential liquidity challenges in meeting short-term obligations.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 26, 2024. Please send any questions or comments about these MetLife pros and cons to contact@marketbeat.com.

MET Stock Analysis - Frequently Asked Questions

How have MET shares performed this year?

MetLife's stock was trading at $66.13 at the beginning of 2024. Since then, MET stock has increased by 12.0% and is now trading at $74.08.
View the best growth stocks for 2024 here
.

How were MetLife's earnings last quarter?

MetLife, Inc. (NYSE:MET) posted its earnings results on Wednesday, July, 31st. The financial services provider reported $2.28 earnings per share for the quarter, beating the consensus estimate of $2.13 by $0.15. The company's revenue was up 7.2% on a year-over-year basis.
Read the conference call transcript
.

Is MetLife doing a stock buyback?

MetLife's Board of Directors approved a stock buyback program on Wednesday, May 1st 2024, which authorizes the company to repurchase $3,000,000,000 in shares, according to EventVestor. This means that the company could purchase up to 6% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board of directors believes its stock is undervalued.

What is Michel Khalaf's approval rating as MetLife's CEO?

308 employees have rated MetLife Chief Executive Officer Michel Khalaf on Glassdoor.com. Michel Khalaf has an approval rating of 89% among the company's employees.

Does MetLife have any subsidiaries?

MetLife subsidiaries include Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and others.

Who are MetLife's major shareholders?

MetLife's top institutional shareholders include Pzena Investment Management LLC (1.36%), Dimensional Fund Advisors LP (0.76%), Legal & General Group Plc (0.75%) and Bank of New York Mellon Corp (0.61%). Insiders that own company stock include Steven J Goulart, Ramy Tadros, Marlene Debel, Bill Pappas, Susan M Podlogar, Jeh C Johnson and Michel Khalaf.
View institutional ownership trends
.

How do I buy shares of MetLife?

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of MetLife own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), General Electric (GE), International Business Machines (IBM), Exxon Mobil (XOM) and Intel (INTC).

This page (NYSE:MET) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners